BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 38725889)

  • 1. Inflammatory Myofibroblastic Tumor of the urinary bladder: A case report.
    Lassiter S; Smith ML; Siegert J; Nguyen T
    Urol Case Rep; 2024 May; 54():102726. PubMed ID: 38799732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory myofibroblastic tumor of the urinary bladder: A systematic review of the literature and report of a case.
    Hage L; O'Donnell MA; Abou Chakra M; Kime A; Sibony M; Peyromaure M; Duquesne I
    Indian J Urol; 2024; 40(2):88-95. PubMed ID: 38725889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update of Diagnosis and Targeted Therapy for ALK
    Wang QA; Chen HW; Wu RC; Wu CE
    Curr Treat Options Oncol; 2023 Dec; 24(12):1683-1702. PubMed ID: 37938503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Systematic Review and Meta-analysis of Perioperative, Oncological, and Quality of Life Outcomes Using Randomized Controlled Trials.
    Khetrapal P; Wong JKL; Tan WP; Rupasinghe T; Tan WS; Williams SB; Boorjian SA; Wijburg C; Parekh DJ; Wiklund P; Vasdev N; Khan MS; Guru KA; Catto JWF; Kelly JD
    Eur Urol; 2023 Oct; 84(4):393-405. PubMed ID: 37169638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory myofibroblastic tumor of the bladder: Computed tomographic features.
    Liang P; Zhu BB; Ren XC; Gao JB
    Mol Clin Oncol; 2023 May; 18(5):40. PubMed ID: 37035472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric inflammatory myofibroblastic tumor of the bladder with ALK-FN1 fusion successfully treated by alectinib.
    Fujiki T; Sakai Y; Ikawa Y; Takenaka M; Noguchi K; Kuroda R; Abe T; Nomura K; Sakai S; Wada T
    Pediatr Blood Cancer; 2023 Apr; 70(4):e30172. PubMed ID: 36635892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory Myofibroblastic Tumor of the Urinary Bladder: An 11-Year Retrospective Study From a Single Center.
    Chen C; Huang M; He H; Wu S; Liu M; He J; Zang H; Xu R
    Front Med (Lausanne); 2022; 9():831952. PubMed ID: 35308527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What do we know about inflammatory myofibroblastic tumors? - A systematic review.
    Siemion K; Reszec-Gielazyn J; Kisluk J; Roszkowiak L; Zak J; Korzynska A
    Adv Med Sci; 2022 Mar; 67(1):129-138. PubMed ID: 35219201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory myofibroblastic tumour of genitourinary system.
    Nauman M; Hasan AS; Sultan G; Kumar P; Hussain M; Hashmi A
    J Pak Med Assoc; 2021 Oct; 71(10):2467-2469. PubMed ID: 34974596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case Report: Circulating Tumor Cells as a Response Biomarker in ALK-Positive Metastatic Inflammatory Myofibroblastic Tumor.
    Bonvini P; Rossi E; Zin A; Manicone M; Vidotto R; Facchinetti A; Tombolan L; Affinita MC; Santoro L; Zamarchi R; Bisogno G
    Front Pediatr; 2021; 9():652583. PubMed ID: 33996693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case series: Inflammatory myofibroblastic bladder tumor in regional Australia.
    Cresser S; Nzenza T; Tripathy S; Hall R
    Int J Surg Case Rep; 2021 May; 82():105898. PubMed ID: 33957398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
    Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Akl EA; Brennan SE; Chou R; Glanville J; Grimshaw JM; Hróbjartsson A; Lalu MM; Li T; Loder EW; Mayo-Wilson E; McDonald S; McGuinness LA; Stewart LA; Thomas J; Tricco AC; Welch VA; Whiting P; Moher D
    BMJ; 2021 Mar; 372():n71. PubMed ID: 33782057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial cystectomy for muscle-invasive bladder cancer: a review of the literature.
    Peak TC; Hemal A
    Transl Androl Urol; 2020 Dec; 9(6):2938-2945. PubMed ID: 33457266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory Myofibroblastic Tumor of the Bladder With FN1-ALK Gene Fusion: Different Response to ALK Inhibition.
    Reinhart S; Trachsel Y; Fritz C; Wagner U; Bode-Lesniewska B; John H; Pless M
    Urology; 2020 Dec; 146():32-35. PubMed ID: 33007314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudosarcomatous myofibroblastic proliferations of the urinary bladder are neoplasms characterized by recurrent FN1-ALK fusions.
    Acosta AM; Demicco EG; Dal Cin P; Hirsch MS; Fletcher CDM; Jo VY
    Mod Pathol; 2021 Feb; 34(2):469-477. PubMed ID: 32908253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory Myofibroblastic Tumor of the Urinary Bladder and Ureter in Children: Experience of a Tertiary Referral Center.
    Li YP; Han WW; Yang Y; He LJ; Zhang WP
    Urology; 2020 Nov; 145():229-235. PubMed ID: 32777366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical cystectomy for management of inflammatory myofibroblastic tumor of the urinary bladder: A rare case report.
    Ayati M; Nowroozi MR; Momeni SA; Moghadam SO; Saffar H; Valizadeh F
    Urol Case Rep; 2019 Nov; 27():100997. PubMed ID: 31463199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALK-negative urachal inflammatory myofibroblastic tumor in an elderly female: A case report.
    Wang K; Zhou H; Lu Y; Lu Q; Zhang C; Zhou X; Xia S; Wang G
    Medicine (Baltimore); 2018 Dec; 97(51):e13619. PubMed ID: 30572472
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.